U.K. Veterinary Medicine Market Size & Outlook, 2026-2033
The veterinary medicine market in the UK is expected to reach a projected revenue of US$ 4,628.6 million by 2033. A compound annual growth rate of 8.6% is expected of the UK veterinary medicine market from 2026 to 2033.
Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago
Other key industry trends
In terms of revenue, UK accounted for 4.7% of the global veterinary medicine market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, UK veterinary medicine market is projected to lead the regional market in terms of revenue in 2033.
Sweden is the fastest growing regional market in Europe and is projected to reach USD 1,142.5 million by 2033.
The UK veterinary medicine market is anticipated to witness lucrative growth over the forecast period. Factors contributing to the market growth are increasing pet ownership, growing adoption of pet insurance, increasing number of strategic initiatives undertaken by key companies, and rising prevalence of number of zoonotic diseases.
For instance, according to the Health and Safety Executive, in the UK, there are around 40 zoonotic diseases currently identified, and approximately 300,000 people in various occupations are vulnerable to these zoonotic diseases, which creates market demand.
For instance, the annual growth rate of pet care revenue is 4.5%, and the average annual spending per dog is USD 3,541.6 (GBP 2,880) & per cat is USD 1,475.7 (GBP 1,200). Such factors are positively influencing the veterinary medicine market in the country.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Medicine Market Outlook will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 62.68% in 2025.
Horizon Databook has segmented the U.K. veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2021 to 2033.
The UK veterinary medicine market is anticipated to witness lucrative growth over the forecast period. Factors contributing to the market growth are increasing pet ownership, growing adoption of pet insurance, increasing number of strategic initiatives undertaken by key companies, and rising prevalence of number of zoonotic diseases.
For instance, according to the Health and Safety Executive, in the UK, there are around 40 zoonotic diseases currently identified, and approximately 300,000 people in various occupations are vulnerable to these zoonotic diseases, which creates market demand.
For instance, the annual growth rate of pet care revenue is 4.5%, and the average annual spending per dog is USD 3,541.6 (GBP 2,880) & per cat is USD 1,475.7 (GBP 1,200). Such factors are positively influencing the veterinary medicine market in the country.
U.K. Veterinary Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
Biologics
Pharmaceuticals
Medicated Feed Additives
U.K. Veterinary Medicine Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
Companion Animals
Production Animals
U.K. Veterinary Medicine Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
Oral
Other Routes
Injectable
Topical
U.K. Veterinary Medicine Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
E-commerce
Offline Retail Stores
Others
Veterinary Hospitals & Clinics
Reasons to subscribe to Veterinary Medicine Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Medicine Market Outlook databook
Our clientele includes a mix of Veterinary Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Veterinary Medicine Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Veterinary Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.